In a recent interview with Pharmaceutical Technology, Dexter Tjoa, CEO of Tjoapack, discusses the trends that are shaping pharmaceutical packaging and influencing decision-making heading into 2026.

Dexter highlights a continued industry shift toward specialization, as pharma companies increasingly seek expert partners to support complex and sensitive products. With the ongoing growth of biologics and biosimilars, formats such as vials and syringes remain in strong demand—reinforcing the need for scalable, reliable packaging strategies.

He also shares a realistic view on sustainability: while interest remains high, product integrity and barrier performance still take priority for primary packaging materials. Progress is moving faster in outer packaging, where recyclable and responsibly sourced materials are gaining traction.

Finally, Dexter points to digitalization as an area of growing impact, with packaging being used in smarter ways through tools like QR codes and digital information leaflets—supporting compliance and improving access to information across the supply chain.

📖 Watch the interview here.

‍